Exercise vs. extended-release niacin in patients with coronary heart disease and low HDL [high density lipoprotein] cholesterol: effect on lipid profile and endothelial function.

Trial Profile

Exercise vs. extended-release niacin in patients with coronary heart disease and low HDL [high density lipoprotein] cholesterol: effect on lipid profile and endothelial function.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Feb 2016

At a glance

  • Drugs Niacin (Primary)
  • Indications Heart disorders; Low HDL cholesterol
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 30 Jul 2012 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov record.
    • 11 Apr 2009 Status changed from recruiting to active, no longer recruiting.
    • 08 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top